PANews reported on June 19 that OpenAI announced that as the capabilities of AI models in the biological field improve, the company is strengthening security protection and working with globalPANews reported on June 19 that OpenAI announced that as the capabilities of AI models in the biological field improve, the company is strengthening security protection and working with global

OpenAI to hold biosafety summit in July to promote safe development of AI bio-capabilities

2025/06/19 12:10

PANews reported on June 19 that OpenAI announced that as the capabilities of AI models in the biological field improve, the company is strengthening security protection and working with global experts, including hosting a biosafety summit in July . OpenAI has cooperated with institutions such as the Los Alamos National Laboratory in the United States to evaluate the application and risks of AI in biological laboratories. The company has launched multiple security measures, such as model rejection of dangerous requests, real-time detection systems, manual review and red team attack and defense testing, and has adopted stricter release control for high-risk models. OpenAI stated that in the future it will work with governments, scientific research institutions and enterprises to enhance biosafety defenses to ensure that AI empowers life sciences while effectively preventing potential biological threats.

Piyasa Fırsatı
BIO Protocol Logosu
BIO Protocol Fiyatı(BIO)
$0.04666
$0.04666$0.04666
+5.16%
USD
BIO Protocol (BIO) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.